CDC committee endorses Pfizer pneumonia vaccine
August 15th 2014A Centers for Disease Control and Prevention (CDC) committee has recommended Prevnar 13 [Pneumococcal 13-valent Conjugate Vaccine] for routine use to help protect adults aged 65 years and older against pneumococcal disease, Pfizer announced.
Need for specialty pharmacy certification grows
August 13th 2014As the field of specialty pharmacy grows and as graduates continue to enter the pharmacy profession, the need for specialty pharmacy certification will grow, said Gary Rice, RPh, MS, MBA, vice president of clinical services for Diplomat Specialty Pharmacy and immediate past president of the Specialty Pharmacy Certification Board (SPCB), during a webinar this week.
Pharmacy professionals in Sierra Leone dead following Ebola outbreak
August 13th 2014Reports received by the International Pharmaceutical Federation (FIP) specify that a pharmacist and four pharmacy technicians from the community practice setting in Sierra Leone have died as a result of the Ebola virus outbreak. Another report from Sierra Leone’s pharmacy board noted that a pharmacy technician who was working in a community pharmacy in Kenema has died.
GSK clinical trial may start this fall for Ebola vaccine
August 12th 2014GlaxoSmithKline (GSK) with its partner, the National Institute of Allergy and Infectious Diseases (NIAID), is expected to begin a phase 1 trial this fall on a potential vaccine for the treatment of Ebola virus, a deadly disease that has killed approximately 1,000 in a recent outbreak in West Africa, according to a report by Reuters.
Mallinckrodt Specialty Generics
August 10th 2014Mallinckrodt Pharmaceuticals started formulating and supplying industry-leading pharmaceutical products more than 146 years ago. Continually building on its legacy, the company employs a vertically integrated process to ensure quality control during every step of the product’s development from active ingredient processing through formulation, manufacturing, and distribution.